| NVAX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the NVAX shares outstanding history going back to 3/11/2010:
Also see: NVAX Market Cap History NVAX YTD Return |
NVAX Shares Outstanding History — Novavax Share Count Over Time
As of 4/30/2026 Novavax has 164.44 million NVAX shares outstanding. Investors often track the NVAX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows NVAX share count trends over time, with 69 historical shares outstanding datapoints presented, dating back to 3/11/2010.
| NVAX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NVAX Historical Shares Outstanding: +24.13% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NVAX Stock Price Chart |
| About Novavax, Inc. |
| Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. Co. offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). We show 69 historical shares outstanding datapoints in our coverage of NVAX's shares outstanding history. Understanding the changing numbers of NVAX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NVAX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NVAX by allowing them to research NVAX shares outstanding history as well as any other stock in our coverage universe. |
| NVAX Current Stock Quote |
Quotes delayed 20 minutes  Free NVAX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| NVAX Share Performance |
| Shares Outstanding Peers |
| Novavax (NVAX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
NVCT Shares Outstanding History NVIV Shares Outstanding History NVNO Shares Outstanding History NVO Shares Outstanding History NVOS Shares Outstanding History NVRO Shares Outstanding History NVST Shares Outstanding History NVTA Shares Outstanding History NVTR Shares Outstanding History NVUS Shares Outstanding History More Healthcare companies » |
NVAX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
